Euroapi SAS
PAR:EAPI
Euroapi SAS
EPS (Diluted)
Euroapi SAS
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
Euroapi SAS
PAR:EAPI
|
EPS (Diluted)
-€1
|
CAGR 3-Years
-148%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sanofi SA
PAR:SAN
|
EPS (Diluted)
€6
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
7%
|
|
|
Ipsen SA
PAR:IPN
|
EPS (Diluted)
€5
|
CAGR 3-Years
-15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
|
Vetoquinol SA
PAR:VETO
|
EPS (Diluted)
€5
|
CAGR 3-Years
8%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Virbac SA
PAR:VIRP
|
EPS (Diluted)
€56
|
CAGR 3-Years
59%
|
CAGR 5-Years
46%
|
CAGR 10-Years
31%
|
|
|
Medincell SA
PAR:MEDCL
|
EPS (Diluted)
€0
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
Euroapi SAS
Glance View
EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.
See Also
What is Euroapi SAS's EPS (Diluted)?
EPS (Diluted)
-1.4
EUR
Based on the financial report for Dec 31, 2024, Euroapi SAS's EPS (Diluted) amounts to -1.4 EUR.
What is Euroapi SAS's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-148%
Over the last year, the EPS (Diluted) growth was 31%. The average annual EPS (Diluted) growth rates for Euroapi SAS have been -148% over the past three years .
